Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Prucalopride Succinate

Prucalopride Succinate
Prucalopride Succinate (Resolor Succinate) is a selective, high affinity 5-HT4 receptor agonist, inhibiting human 5-HT(4a) and 5-HT(4b) receptor with Ki value of 2.5 nM and 8 nM, respectively.
Catalog No. T6958Cas No. 179474-85-2
Select Batch
Purity:99.24%
Contact us for more batch information

Resource Download

Prucalopride Succinate

Catalog No. T6958Alias Resolor Succinate, R-108512Cas No. 179474-85-2

Prucalopride Succinate (Resolor Succinate) is a selective, high affinity 5-HT4 receptor agonist, inhibiting human 5-HT(4a) and 5-HT(4b) receptor with Ki value of 2.5 nM and 8 nM, respectively.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
10 mg$40In Stock
25 mg$50In Stock
50 mg$68In Stock
100 mg$115In Stock
200 mg$181In Stock
1 mL x 10 mM (in DMSO)$30In Stock
Bulk & Custom
Add to Cart

Related Compound Libraries of "Prucalopride Succinate"

Product Introduction

Bioactivity
Description
Prucalopride Succinate (Resolor Succinate) is a selective, high affinity 5-HT4 receptor agonist, inhibiting human 5-HT(4a) and 5-HT(4b) receptor with Ki value of 2.5 nM and 8 nM, respectively.
Targets&IC50
5-HT4B:8 nM(Ki), 5-HT4A:2.5 nM(Ki)
In vitro
Prucalopride induces contractions in a concentration-dependent manner with pEC50 of 7.5. Prucalopride (1 mM) significantly amplifies the rebound contraction of the guinea-pig proximal colon after electrical field stimulation. Prucalopride induces relaxation of the rat oesophagus preparation of rat oesophagus tunica muscularis mucosae with pEC50 of 7.8, yielding a monophasic concentration–response curve. [1] Prucalopride (0.1 μM) concentration-dependently increases the amplitude of submaximal cholinergic contractions and of acetylcholine release induced by electrical field stimulation in pig gastric circular muscle, and the effect is induced and enhanced IBMX (10 μM). [2] Prucalopride (1 μM) significantly enhances the electrically induced cholinergic contractions in pig descending colon, and the facilitating effect is significantly enhanced by Rolipram. [3]
In vivo
Prucalopride alters colonic contractile motility patterns in a dose-dependent fashion by stimulating high-amplitude clustered contractions in the proximal colon and by inhibiting contractile activity in the distal colon of fasted dogs. Prucalopride also causes a dose-dependent decrease in the time to the first giant migrating contraction (GMC); at higher doses of prucalopride, the first GMC generally occurres within the first half-hour after treatment. [4]
AliasResolor Succinate, R-108512
Chemical Properties
Molecular Weight485.96
FormulaC18H26ClN3O3·C4H6O4
Cas No.179474-85-2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: 89 mg/mL (183.1 mM)
DMSO: 90 mg/mL (185.2 mM)
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM2.0578 mL10.2889 mL20.5778 mL102.8891 mL
5 mM0.4116 mL2.0578 mL4.1156 mL20.5778 mL
10 mM0.2058 mL1.0289 mL2.0578 mL10.2889 mL
20 mM0.1029 mL0.5144 mL1.0289 mL5.1445 mL
50 mM0.0412 mL0.2058 mL0.4116 mL2.0578 mL
100 mM0.0206 mL0.1029 mL0.2058 mL1.0289 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Prucalopride Succinate | purchase Prucalopride Succinate | Prucalopride Succinate cost | order Prucalopride Succinate | Prucalopride Succinate chemical structure | Prucalopride Succinate in vivo | Prucalopride Succinate in vitro | Prucalopride Succinate formula | Prucalopride Succinate molecular weight